Breast Cancer-Derived Microvesicles Are the Source of Functional Metabolic Enzymes as Potential Targets for Cancer Therapy

Risha, Yousef and Susevski, Vanessa and Hüttmann, Nico and Poolsup, Suttinee and Minic, Zoran and Berezovski, Maxim V. (2021) Breast Cancer-Derived Microvesicles Are the Source of Functional Metabolic Enzymes as Potential Targets for Cancer Therapy. Biomedicines, 9 (2). p. 107. ISSN 2227-9059

[thumbnail of biomedicines-09-00107.pdf] Text
biomedicines-09-00107.pdf - Published Version

Download (1MB)

Abstract

Membrane-derived extracellular vesicles, referred to as microvesicles (MVs), have been proposed to participate in several cancer diseases. In this study, MV fractions were isolated by differential ultracentrifugation from a metastatic breast cancer (BC) cell line MDA-MB-231 and a non-cancerous breast cell line MCF10A, then analyzed by nano-liquid chromatography coupled to tandem mass spectrometry. A total of 1519 MV proteins were identified from both cell lines. The data obtained were compared to previously analyzed proteins from small extracellular vesicles (sEVs), revealing 1272 proteins present in both MVs and sEVs derived from the MDA-MB-231 cell line. Among the 89 proteins unique to MDA-MB-231 MVs, three enzymes: ornithine aminotransferase (OAT), transaldolase (TALDO1) and bleomycin hydrolase (BLMH) were previously proposed as cancer therapy targets. These proteins were enzymatically validated in cells, sEVs, and MVs derived from both cell lines. The specific activity of OAT and TALDO1 was significantly higher in MDA-MB-231-derived MVs than in MCF10A MVs. BLMH was highly expressed in MDA-MB-231-derived MVs, compared to MCF10A MVs. This study shows that MVs carry functional metabolic enzymes and provides a framework for future studies of their biological role in BC and potential in therapeutic applications.

Item Type: Article
Subjects: Apsci Archives > Biological Science
Depositing User: Unnamed user with email support@apsciarchives.com
Date Deposited: 29 Dec 2022 07:50
Last Modified: 13 Sep 2023 08:13
URI: http://eprints.go2submission.com/id/eprint/2

Actions (login required)

View Item
View Item